DawMed Systems PLC
27 April 2007
For Immediate Release 27 April 2007
Dawmed Systems Plc
('Dawmed' or the 'Company')
Director's Shareholdings
On 25 April 2007 Integrated Financial Arrangements Plc, as Trustees for the
Nicholas Trigg Self Invested Personal Pension scheme, purchased 104,755 Ordinary
Shares of 5p each at 11p per share. Nicholas Trigg is a Non-Executive Director
of the Company and his underlying interest in the share capital of the Company
is now as set out below.
As a result of this purchase, the Company has received a notification to this
effect:
Number of Ordinary
Shares
Nicholas Trigg
Shares -
Option 100,000 Ordinary Shares of 5p
each
Integrated Financial
Arrangements
Plc (as Trustee of the 104,755 Ordinary Shares of 5p
Nicholas ------- each
Trigg SIPP)
TOTAL 204,755
-------
Representing in aggregate 1.00% of the Company's issued share capital.
Enquiries: Kevin Gilmore 01789 740010
Executive Chairman
DawMed Systems plc
Roland Cornish 0207 628 3396
Chairman
Beaumont Cornish Limited
Maxine Barnes/Dominic Barretto 0207 562 3350
Bishopsgate Communications Limited
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.